These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 9178476

  • 1. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
    Dunne M, al-Ramadi BK, Barthold SW, Flavell RA, Fikrig E.
    Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
    Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.
    Vaccine; 1999 Feb 26; 17(7-8):904-14. PubMed ID: 10067697
    [Abstract] [Full Text] [Related]

  • 8. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, Patrican LA, Mohammed H, Summers BA.
    Infect Immun; 1995 Sep 26; 63(9):3543-9. PubMed ID: 7642289
    [Abstract] [Full Text] [Related]

  • 9. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.
    Fikrig E, Barthold SW, Kantor FS, Flavell RA.
    J Infect Dis; 1991 Dec 26; 164(6):1224-7. PubMed ID: 1955724
    [Abstract] [Full Text] [Related]

  • 10. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
    Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC.
    Infect Immun; 1997 Mar 26; 65(3):882-9. PubMed ID: 9038292
    [Abstract] [Full Text] [Related]

  • 11. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan 26; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

  • 12. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L, Rais O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, Pêtre J.
    Immunol Lett; 1994 Mar 26; 39(3):249-58. PubMed ID: 8034340
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Klouwens MJ, Salverda MLM, Trentelman JJ, Ersoz JI, Wagemakers A, Gerritzen MJH, van der Ley PA, Hovius JW.
    Vaccine; 2021 Apr 28; 39(18):2561-2567. PubMed ID: 33812741
    [Abstract] [Full Text] [Related]

  • 14. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang Y, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers T, Quimby FW, Shin S, Lein DH.
    Vaccine; 1999 Oct 14; 18(5-6):540-8. PubMed ID: 10519945
    [Abstract] [Full Text] [Related]

  • 15. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM, Gern L, Hauser P, Zhong W, Nielsen PJ, Kramer MD, Brenner C, Wallich R.
    Eur J Immunol; 1996 Dec 14; 26(12):2831-40. PubMed ID: 8977275
    [Abstract] [Full Text] [Related]

  • 16. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul 14; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 17. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J.
    Vaccine; 1995 Aug 14; 13(12):1086-94. PubMed ID: 7491816
    [Abstract] [Full Text] [Related]

  • 18. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES, Champion CI, Wu XY, Skare JT, Blanco DR, Miller JN, Lovett MA.
    Infect Immun; 2000 Jul 14; 68(7):4189-99. PubMed ID: 10858236
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
    Schwendinger MG, O'Rourke M, Traweger A, Savidis-Dacho H, Pilz A, Portsmouth D, Livey I, Barrett PN, Crowe BA.
    PLoS One; 2013 Jul 14; 8(11):e79022. PubMed ID: 24260146
    [Abstract] [Full Text] [Related]

  • 20. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.
    Fikrig E, Barthold SW, Persing DH, Sun X, Kantor FS, Flavell RA.
    J Immunol; 1992 Apr 01; 148(7):2256-60. PubMed ID: 1545130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.